The Nova Primary blood glucose reference analyzer meets the requirements of glucose device manufacturers and clinical researchers for an accurate, user-friendly replacement for the discontinued ...

The ABL9 blood gas analyzer is intended specifically for critical care conditions where just a few tests are performed each day. It is designed with comfort in mind, and its small footprint allows ...

The global blood gas and electrolyte analyzers market was valued at USD 2.7 Billion in 2022 and is projected to grow at a CAGR of 6.9% from 2023 to 2031, reaching USD 5.0 Billion by 2031. The growth ...

As a standalone technology, the HYLA targets the blood gas analyzer market, projected to reach $5.7 billion by 2030, while also strengthening Inspira's position in the $19 billion mechanical ...

Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a key parameter, targeting multiple multi-billion-dollar market segments; Company plans to ...

The company reported that the HYLA successfully achieved 96% accuracy in its clinical study results for a key parameter, as compared to traditional blood test analyzers. In addition, the clinical ...